These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25787215)

  • 1. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.
    Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I
    Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome.
    Ng BK; Lee CL; Lim PS; Othman H; Ismail NAM
    Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28586302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.
    Li HW; Brereton RE; Anderson RA; Wallace AM; Ho CK
    Metabolism; 2011 Oct; 60(10):1475-81. PubMed ID: 21550088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.
    Bacopoulou F; Kolias E; Efthymiou V; Antonopoulos CN; Charmandari E
    Eur J Clin Invest; 2017 Oct; 47(10):746-755. PubMed ID: 28795765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
    Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
    Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 25-Hydroxy Vitamin D Levels in Turkish Adolescent Girls with Polycystic Ovary Syndrome and the Correlation with Clinical/Biochemical Parameters.
    Bostanci EI; Ozler S; Yilmaz NK; Yesilyurt H
    J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):270-273. PubMed ID: 28782659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
    Velija-Ašimi Z
    Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link?
    Cappy H; Giacobini P; Pigny P; Bruyneel A; Leroy-Billiard M; Dewailly D; Catteau-Jonard S
    Ann Endocrinol (Paris); 2016 Oct; 77(5):593-599. PubMed ID: 26997468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.
    Santos BR; Lecke SB; Spritzer PM
    PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
    Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.